Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |